Fabtech Technologies — 360° view

Fabtech Technologies, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹92 crore and net profit of ₹15 crore for the September 2026 quarter.

Fabtech Technologies (NSE: FABTECH) closed at ₹140.37 on 20 Nov 2026, down 41.2% over the past year. Its market capitalisation is ₹624 crore and it trades at 21.0 times earnings.

Share price
₹140.37 (20 Nov 2026)
Market cap
₹624 Cr (20 Nov 2026)
P/E
20.96 (20 Nov 2026)
Revenue
₹92 Cr (September 2026 quarter)
Net profit
₹15 Cr (September 2026 quarter)
ROCE
13.9% (FY26)
ROE
12.0% (FY26)
Book value
₹98.8 (FY26)
Dividend yield
0.43% (last 12 months to 20 Nov 2026)
52-week high / low
₹256.95 / ₹115.10 (20 Nov 2026)
1-year return
-41.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Research, Analytics & Technology
Symbol
NSE: FABTECH

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.